{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:06:08Z","timestamp":1770822368589,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T00:00:00Z","timestamp":1297123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1477-7819-9-19","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T10:06:28Z","timestamp":1297159588000},"source":"Crossref","is-referenced-by-count":22,"title":["Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study"],"prefix":"10.1186","volume":"9","author":[{"family":"Chintamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,8]]},"reference":[{"key":"964_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1023\/A:1020274709327","volume":"76","author":"H Cure","year":"2002","unstructured":"Cure H, Amat S, Penault-Llorca F, le Bou\u00ebdec G, Ferri\u00e8re JP, Mouret-Reynier MA, Kwiatkowski F, Feillel V, Dauplat J, Chollet P: Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy. Breast Cancer res Treat. 2002, 76: 37-45. 10.1023\/A:1020274709327.","journal-title":"Breast Cancer res Treat"},{"key":"964_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0002-9610(98)00253-0","volume":"176","author":"HM Kuerer","year":"1998","unstructured":"Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE: Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease free survival in patients with locally advanced breast cancer. Am J Surg. 1998, 176: 502-9. 10.1016\/S0002-9610(98)00253-0.","journal-title":"Am J Surg"},{"key":"964_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1200\/JCO.20.5.1304","volume":"20","author":"R Rouzier","year":"2002","unstructured":"Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, Vincent-Salomon A, Vielh P, Bourstyn E: Incidence and prognostic signioficance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 2002, 20: 1304-10. 10.1200\/JCO.20.5.1304.","journal-title":"J Clin Oncol"},{"key":"964_CR4","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB, Hoehn JL, Lees AW, Dimitrov NV, Bear HD: Effect of pre-operative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998, 16: 2672-2685.","journal-title":"J Clin Oncol"},{"key":"964_CR5","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","volume":"19","author":"JA Van der Hage","year":"2002","unstructured":"Van der Hage JA, Van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L, van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L: Preoperative chemotherapy in primary operable breast cancer: results from the European Organisation for Research and Treatment of Cancer trial 10902. J Clin Oncol. 2002, 19: 4224-37.","journal-title":"J Clin Oncol"},{"key":"964_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jnci\/dji021","volume":"97","author":"D Mauri","year":"2005","unstructured":"Mauri D, Pavlisdis N, Ioannidis JP: Neoadjuvant vs adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005, 97: 188-94. 10.1093\/jnci\/dji021.","journal-title":"J Natl Cancer Inst"},{"key":"964_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/bjs.5894","volume":"94","author":"JS Mieog","year":"2007","unstructured":"Mieog JS, Van der Hage JA, Van de Velde CJ: Neoadjuvant chemotherapy for operable breast cancer. Br J Surg. 2007, 94: 1189-2000. 10.1002\/bjs.5894.","journal-title":"Br J Surg"},{"key":"964_CR8","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV: Effect of preoperative chemotherapy on loco-regional disease in women with operable breast cancer: findings from NSABP B-18. J Clin Oncol. 1997, 15: 2483-93.","journal-title":"J Clin Oncol"},{"key":"964_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jnci\/82.19.1539","volume":"82","author":"G Bonadonna","year":"1990","unstructured":"Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, Bartoli C, Coopmans de Yoldi G, Zucali R, Rilke F: Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst. 1990, 82: 1539-45. 10.1093\/jnci\/82.19.1539.","journal-title":"J Natl Cancer Inst"},{"key":"964_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.1995.13.3.537","volume":"13","author":"B Fisher","year":"1995","unstructured":"Fisher B, Mamounas EP: Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol. 1995, 13: 537-40.","journal-title":"J Clin Oncol"},{"key":"964_CR11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1245\/ASO.2004.03.512","volume":"11","author":"JS Rietman","year":"2004","unstructured":"Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJl: Treatment related upper limb morbidity 1 year after sentinel node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol. 2004, 11: 1018-24. 10.1245\/ASO.2004.03.512.","journal-title":"Ann Surg Oncol"},{"key":"964_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K","volume":"88","author":"P Schrenk","year":"2000","unstructured":"Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000, 88: 608-14. 10.1002\/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K.","journal-title":"Cancer"},{"key":"964_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","volume":"230","author":"HM Kuerer","year":"1999","unstructured":"Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999, 230: 72-8. 10.1097\/00000658-199907000-00011.","journal-title":"Ann Surg"},{"key":"964_CR14","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, Bear HD, Caldwell CB, Walker AP, Mikkelson WM, Stauffer JS, Robidoux A, Theoret H, Soran A, Fisher B, Wickerham DL, Wolmark N: Sentinel node biopsy after neo-adjuvant chemotherapy in chemotherapy in breast cancer: results from NSABP protocol B-27. J Clin Oncol. 2005, 23: 2694-702. 10.1200\/JCO.2005.05.188.","journal-title":"J Clin Oncol"},{"key":"964_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/bjs.5209","volume":"93","author":"Y Xing","year":"2006","unstructured":"Xing Y, Foy M, Cox DD: Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg. 2006, 93: 539-46. 10.1002\/bjs.5209.","journal-title":"Br J Surg"},{"key":"964_CR16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1056\/NEJM199810013391401","volume":"339","author":"D Krag","year":"1998","unstructured":"Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1998, 339: 941-6. 10.1056\/NEJM199810013391401.","journal-title":"N Engl J Med"},{"key":"964_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00000658-200101000-00009","volume":"233","author":"L Tafra","year":"2001","unstructured":"Tafra L, Lannin DR, Swanson MS, Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001, 233: 51-59. 10.1097\/00000658-200101000-00009.","journal-title":"Ann Surg"},{"key":"964_CR18","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1200\/JCO.2000.18.13.2560","volume":"18","author":"KM McMasters","year":"2000","unstructured":"McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, Edwards MJ: Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000, 18: 2560-6.","journal-title":"J Clin Oncol"},{"key":"964_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/BF02557365","volume":"9","author":"PJ Tanis","year":"2002","unstructured":"Tanis PJ, Nieweg OE, Hart AA, Kroon BB: The illusion of the learning phase for lymphatic mapping. Ann surg Oncol. 2002, 9: 142-7. 10.1007\/BF02557365.","journal-title":"Ann surg Oncol"},{"key":"964_CR20","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1200\/JCO.2000.18.20.3480","volume":"18","author":"TM Breslin","year":"2000","unstructured":"Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK: Sentinel lymph node is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000, 18: 3480-3486.","journal-title":"J Clin Oncol"},{"key":"964_CR21","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-#","volume":"89","author":"KS Nason","year":"2000","unstructured":"Nason KS, Anderson BO, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, Livingston R, Schmidt RA, Jewell KD, Yeung RS, Moe RE: Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer. 2000, 89: 2187-2194. 10.1002\/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-#.","journal-title":"Cancer"},{"key":"964_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0002-9610(01)00736-X","volume":"182","author":"TB Julian","year":"2001","unstructured":"Julian TB, Patel N, Dusi D, Olson P, Nathan G, Jasnosz K, Isaacs G, Wolmark N: Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J surg. 2001, 182: 407-410. 10.1016\/S0002-9610(01)00736-X.","journal-title":"Am J surg"},{"key":"964_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/00006231-200104000-00003","volume":"22","author":"A Fern\u00e1ndez","year":"2001","unstructured":"Fern\u00e1ndez A, Cort\u00e9s M, Benito E, Azpeitia D, Prieto L, Moreno A, Ricart Y, Mora J, Escobedo A, Mart\u00edn Com\u00edn J: Gamma probe sentinel node localization and biopsy in breast cancer patient treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun. 2001, 22: 361-366.","journal-title":"Nucl Med Commun"},{"key":"964_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02573060","volume":"9","author":"V Stearns","year":"2002","unstructured":"Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN: Sentinel lymphadenopathy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast carcinoma. Ann Surg Oncol. 2002, 9: 235-242. 10.1007\/BF02573060.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"964_CR25","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/1097-0142(20010901)92:5<1080::AID-CNCR1423>3.0.CO;2-1","volume":"92","author":"A Haid","year":"2001","unstructured":"Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, Breitfellner G, Sega W, Aufschnaiter M, Sturn H, Zimmermann G: Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma?. Cancer. 2001, 92 (5): 1080-4. 10.1002\/1097-0142(20010901)92:5<1080::AID-CNCR1423>3.0.CO;2-1.","journal-title":"Cancer"},{"key":"964_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02573061","volume":"9","author":"AR Miller","year":"2002","unstructured":"Miller AR, Thomason VE, Yeh IT, Alrahwan A, Sharkey FE, Stauffer J, Otto PM, McKay C, Kahlenberg MS, Phillips WT, Cruz AB: Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol. 2002, 9: 243-247. 10.1007\/BF02573061.","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-9-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7819-9-19\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-9-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T04:53:33Z","timestamp":1548132813000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-9-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-9-19","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,8]]},"article-number":"19"}}